IFF
60
-6
STX
63
-3
CL
59
-3
SNA
52
2
ABBV
59
9
PAYX
45
7
OMC
53
-2
HBAN
79
5
MCK
62
-5
NWL
61
3
SLB
44
5
VRTX
57
8
MKC
42
-3
MSFT
40
-4
INTU
53
2
EQT
65
8
IP
42
8
O
57
2
TGNA
53
2
ADP
65
4
IFF
60
-6
STX
63
-3
CL
59
-3
SNA
52
2
ABBV
59
9
PAYX
45
7
OMC
53
-2
HBAN
79
5
MCK
62
-5
NWL
61
3
SLB
44
5
VRTX
57
8
MKC
42
-3
MSFT
40
-4
INTU
53
2
EQT
65
8
IP
42
8
O
57
2
TGNA
53
2
ADP
65
4
Financhill
Back

PROCEPT BioRobotics Corp. 10K Form

Sell
44

PRCT
PROCEPT BioRobotics Corp.

Last Price:
$35.44
Seasonality Move:
-13.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PRCT News And Ratings

See the #1 stock for the next 7 days that we like better than PRCT

PRCT Financial Statistics

Sales & Book Value

Annual Sales: $224.5M
Cash Flow: $-9.5M
Price / Cash Flow: 0
Annual Sales: $6.81
Price / Book: 4.88

Profitability

EPS (TTM): -1.53790
Net Income (TTM): $-84.6M
Gross Margin: $137.1M
Return on Equity: -23.51%
Return on Assets: -17.25%

PROCEPT BioRobotics Corp. Earnings Forecast

Key PROCEPT BioRobotics Corp. Financial Ratios

  • The Gross Profit Margin over the past 6 years for PRCT is 61.07%.
  • The Selling, General & Administrative Expenses for PRCT have been equal to 76.35% of Gross Profit Margin.
  • The Research & Development expenses have been 27.75% of Revenue.
  • The Net Earning history of PRCT is -40.72% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 1 years.

PROCEPT BioRobotics Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: PRCT
Website: procept-biorobotics.com

Debt

Debt-to-Equity Ratio: 0.21
Current Ratio: 8.43
Quick Ratio: 7.07

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PRCT Technical Analysis vs Fundamental Analysis

Sell
44
PROCEPT BioRobotics Corp. (PRCT) is a Sell

Is PROCEPT BioRobotics Corp. a Buy or a Sell?